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ABSTRACT
Objective: Unexplained syncope is a challenge facing electrophysiologists. The prognosis varies widely depending on underlying causes, spe-
cially, cardiac ones. We sought to determine the abnormal electrophysiolgic (EP) study results as predictors of prognosis in syncope patients 
with suspected cardiac cause and risk factors associated with mortality.
Methods: A total of 227 consecutive patients with unexplained syncope were prospectively enrolled in this study. EP study was performed in 
177 patients in base of inclusion criteria. These patients, in whom a cardiac cause of syncope was suspected, underwent EP study and if 
negative, head-up tilts test (HUTT). Complete follow-up was obtained for 132 patients for 20.0±10.8 months.
Results: A cardiac cause of syncope was established in 35%, a neurally mediated syncope in 35.6%, and in the rest 29.4% the cause of syn-
cope remained unexplained despite a throughout neurologic and cardiologic evaluation. Logistic analysis revealed that the significant predic-
tors of a cardiac cause of syncope were the absence of prodromal symptoms, left bundle branch block (LBBB), sever left ventricle (LV) dysfunc-
tion and male gender. At logistic analysis, the presence of LBBB (OR=6.63; 95% CI: 1.09-40) was significantly associated with outcome of death. 
Conclusion: The present study provides evidence that presence of LBBB, abnormal EP study result and structural heart disease (SHD) have 
prognostic value in patients with suspected cardiac cause of syncope. The patients with SHD and unexplained syncope who had a negative 
EP study have a good long-term prognosis even in the presence of LV dysfunction. (Anatol J Cardiol 2015; 15: 213-7)
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Predicting the outcome in patients with unexplained syncope and 
suspected cardiac cause: Role of electrophysiologic studies
Introduction
Syncope is a problem that can be caused by different etiolo-
gies ranging from benign self-limiting to malignant recurrent and 
potentially fatal events. Individuals presenting with syncope com-
prise 3% to 5% of emergency department visits and 1% to 3% of 
hospital admissions (1-4). Nearly 50% of the population may have 
at least a syncopal event during their life. In about 25% of patients 
with syncope, the history in combination with physical examination 
is sufficient to establish a diagnosis. Whereas in 40% of patients, 
the cause of syncope remains unknown after extensive clinical 
workup (5, 6). The disappointing results of ambulatory ECG moni-
toring are well known, since the heart rhythm of the patient is 
seldom monitored during an event (7, 8). The major difficulties to 
diagnosis are the unpredictable and uncommon nature of events 
and the high spontaneous recovery. Because of the transient 
nature of these episodes, the underlying causes may remain undi-
agnosed. An electrophysiolgic study (EP) study is often performed 
to elucidate the potential arrhythmic basis for unexplained synco-
pe; especially in patients with underlying structural heart disease 
(9, 10). While the EP study is a potent method to diagnose arrhyth-
mias and help to guide therapy, it has several limitations. Some 
subgroups of patients did not benefit from an EP study, meaning 
that the EP results were non-diagnostic. Identification of these 
patients is important so that the risk and expense of EP study could 
be avoided (11-13). Prognosis of syncope varies widely and 1-year 
mortality may range from 0% in the case of vasovagal events up to 
30% in the presence of heart disease (7, 14, 15). 
The primary aim of this study was to determine the role of 
abnormal EP study in prediction of outcome in syncope patients 
with suspected cardiac cause. The second aim of this study was 
to assess the rate of long-term adverse outcome in terms of 
mortality and to determine the risk factors associated with mor-
tality in this group.
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Methods
Study population
From 2008 to 2010, 227 consecutive patients presented with 
syncope referred to our electrophysiology and pacing 
Department of Pacemaker and Electrophysiology, Rajaie 
Cardiovascular Research and Medical Center, Tehran-Iran. 
Patients were recruited if they have a syncopal episode in the 
previous two months. All patients underwent standard workup 
including history, physical examination, 12-lead ECG, 24-hour 
Holter monitoring, echocardiography, carotid sinus massage and 
neurological evaluation.
Brugada syndrome, mitral valve prolapse, long QT syndrome, 
severe aortic stenosis, and atrial myxoma were excluded. 
Uniform testing protocol was considered for all patients with 
suspected cardiac cause of syncope. According to the results of 
the initial evaluation, 177 patients (70.1% male; mean age 
61.3±16.0 years) with one or some of the following criteria were 
included: 1) the presence of structural heart disease (coronary 
artery disease, ventricular dysfunction, severe mitral or aortic 
valve regurgitation, hypertrophic cardiomyopathy) 2) family his-
tory of sudden cardiac death 3) abnormal ECG or significant 
cardiac arrhythmia in 24-hour Holter monitoring. These patients, 
in whom a cardiac cause of syncope was suspected, underwent 
EP study and if negative, a head-up tilt test (HUTT).
The presence of bundle branch block, first degree atrioven-
tricular block (AVB), Q wave on 12-lead surface ECG were con-
sidered as ECG abnormalities. Frequent non-sustained ventricu-
lar tachycardia (VT) (more than two episodes) during 24-hour 
Holter monitoring was considered significant. Major trauma 
during episodes defined as any fractures, head injury, internal 
organ damage or syncope leading to an car crash. Minor trauma 
defined as soft tissue injury.
All patients had been asked if they had prodromal symptoms 
including cold sweating, nausea and/or vomiting, lightheaded-
ness, impending doom, visual blurring, non-paroxysmal palpita-
tion, weakness and abdominal or chest discomfort.
Syncope was defined as sudden transient loss of conscious-
ness and postural tone with spontaneous recovery caused by 
global cerebral hypoperfusion. A vasovagal or neurally mediated 
response to HUTT was defined as reproduction of syncope or 
presyncope in association with hypotension, bradycardia or 
both (decrease in systolic blood pressure >50% and decrease in 
heart rate >30% of the maximal value observed in upright posi-
tion). Given a lack of a well described definition of near syncope, 
these patients were not included. The protocol of the study was 
approved by our Research Ethical Committee and the informed 
written consents were taken from the all patients.
Electrophysiological study
The electroplysciological study (EP) study included mea-
surement of corrected sinus node recovery time, HV interval at 
baseline and incremental pacing, inducibility of ventricular 
arrhythmia by means of programmed ventricular stimulation in 
two drive cycle lengths (600 ms, 400 ms) with up to three extra-
stimuli and programmed atrial stimulation. EP study was considered 
diagnostic in the presence of: 1- an abnormal sinus node recovery 
time; 2- baseline HV interval ≥100 ms, second or third degree His-
Purkinje block demonstrated by incremental atrial pacing or elicited 
by intravenous procainamide (10 mg/kg over 10 min) 3-induction of 
sustained monomorphic ventricular tachycardia or rapid supraven-
tricular tachycardia that reproduced symptoms.
Head-up tilt test
HUTT test was performed in all patients with unexplained 
syncope if EP study was negative based on standard protocol. 
The patients received no oral intake for more than 6 hr before 
HUTT. An intravenous line was placed for fluid administration. At 
least 20 minute resting period after intravenous line placement, 
the patient was elevated to 70° until syncope occurred. 
Sublingual nitroglycerin (400 µg) was used for drug provocation 
if passive phase had been negative. Drug provocation phase 
duration was 15 minute. The test was considered positive in 
case of bradycardia, hypotension (systolic blood pressure <70 
mm Hg) and syncope.
Outcome measures
All enrolled patients had at least one episode of syncope 
meeting the above definition to be eligible for enrollment. Severe 
outcome was assessed by evaluating mortality. Outcomes were 
determined by inpatient diagnosis, follow-up phone call, and 
subsequent medical records.
Statistical analysis
Continuous variables were expressed as mean±SD. The data 
were tested for normal distribution via the Kolmogorov-Smirnov 
(K-S) test. Logistic regression analysis was used to identify vari-
ables that increased the probability of a positive response. 
Potential predictors of mortality were first individually evaluated 
and then analyzed by binary logistic regression analysis with a 
stepwise backward selection strategy. P value <0.05 was con-
sidered statistically significant. Analysis of data was performed 
using SPSS 15 statistical software (SPSS Inc, Chicago, IL, USA).
Results
Characteristics of patients
The characteristics of patients are shown in Table 1. Seventy 
percent of patients were male. Mean age of patients was 
61.3±16.0 years. Fifty-three percent of patients had coronary 
artery disease, 4.5% dilated cardiomyopathy and 3.9% valvular 
heart disease. ECG abnormalities including right bundle branch 
block and left bundle branch block (LBBB) found in 15% and 5% 
and old myocardial infarction in 26% and 3.6% of patients with 
abnormal and normal EP study, respectively. Twenty-eight per-
cent of patients had a history of physical injury during syncopal 
attack. Syncope occurred in upright position in 76.6%, in supine 
position in 8.5% and in sitting position in 14.9% of the patients. 
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The time interval between the first and last episode of syncope was 
89.0±53.7 days and the number of syncopal attacks was 2.6±1.9. 
Twenty-five percent of patients cited prodromal symptoms.
Electrophysiologic characteristics
A cardiac cause of syncope was established in 35.0% (n=62), 
a neurally mediated syncope in 35.6% (n=63), and in 29.4% (n=52) 
the remaining the cause of syncope remained unexplained 
despite a through neurologic and cardiologic evaluation. In all 
patients with a cardiac cause of syncope, the diagnosis was 
made during the EP study: AV block requiring pacemaker in 7 
patients (11.3%), sinus node dysfunction in 6 (9.7%), VT in 47 
(75.8%), supraventricular tachycardia in 3.2%. In patients with a 
negative EP study result, the diagnosis of neurally mediated 
syncope was made based on positive HUTT result in 35.6%. 
Mean ventricular ejection fraction was 31.28±12.96 percent in 
patients with a cardiac cause of syncope and 47.23±9.60 per-
cent in patients with negative EP study (p<0.001).
Predictors of cardiac cause of syncope
Logistic regression analysis revealed that the significant 
predictors of a cardiac cause of syncope were absence of pro-
dromal symptoms, LBBB, severe left ventricular (LV) dysfunction 
and male gender (p=0.002, p<0.001, p<0.001 and p=0.010 respec-
tively). Position of patients during syncope, number of syncopal 
attacks, the time interval between the first and the last episode 
of syncope, history of injury and age didn’t have any relationship 
with cardiac cause (All p values >0.05). Of noted, we could not 
show any association between the presence of prodromal 
symptoms and cause of syncope (p=0.260).
Follow-up
The mean follow-up period was 20.0±10.8 months. Complete 
follow-up was obtained for 132 patients. Among these, 48 
patients (36.4%) had a positive EP study result, 44 patients 
(33.3%) had a positive HUTT result and the remaining had no 
diagnosis. The 1-year overall mortality was 7.6%. At univariate 
analysis, the risk factors significantly associated with the long-
term outcome of death were a history of myocardial infarction 
(MI), structural heart disease, LV dysfunction, abnormal ECG at 
presentation, use of diuretics, ventricular arrhythmias, and 
abnormal EPS result. At multivariate analysis, none of them were 
independent risk factors for the development of severe adverse 
outcome. In a subgroup analysis of patients with structural heart 
disease, the risk factors significantly associated with outcome 
of death included history of MI, use of diuretics, presence of 
bundle branch block (BBB), abnormal EP study result, ventricular 
arrhythmias, and LV dysfunction (Table 2). At logistic analysis, 
the presence of LBBB (OR 6.63; 95% CI 1.09 to 40) was signifi-
cantly associated with outcome of death (Table 2). In patients 
without structural heart disease, severe outcome could not be 
predicted by clinical characteristics and or EP study result.
Discussion
The causes of syncope are often benign, but can sometimes 
be due to potentially life-threatening disorders. These patients 
are frequently referred for an EP study (16, 17). On the basis of 
the premise that most cardiogenic syncope is related to an 
arrhythmia, tachyarrhythmia, or bradyarrhythmia, electrophysi-
ological testing makes sense. The performance of a diagnostic 
protocol of syncope is clearly influenced by patient selection 
(18, 19). 
In this study, EP study abnormalities have been identified in 
35.5% of patients with otherwise unexplained syncope, with 
ventricular tachycardia the most common abnormality (75.8%). 
EP study was performed in the hope of not only identificating 
Number of patients 177
Patients age, years 61.3±16.0
Sex, male (%) 70.1%
Underlying heart disease, n (%):
Coronary artery disease 94 (53.1%)
Dilated cardiomyopathy 8 (4.5%)
Valvular heart disease 7 (3.9%)
Medications, n (%):
Beta-blocker 78 (59.1%)
Diuretics 38 (28.8%)
Vasodilators 49 (37.1%)
ACE inhibitors 74 (56.1%)
Number of syncope 2.6±1.9
Patients with injury, %:
major 6 (3.4%)
minor 43 (24.3%)
Time interval*, day 89.0±53.7
*Time interval between first and last episode of syncope (day) 
ACE inhibitors - angiotensin converting enzyme inhibitors
Table 1. Patient's baseline characteristics
Univariate analysis: P value
LVEF<40% 0.009
Use of diuretics 0.011
History of MI 0.043
Ventricular tachycardia 0.006
Presence of LBBB <0.001
Abnormal EP result 0.007
Binary logistic regression:
  95%
 Odds Ratio Confidence Interval
Presence of LBBB 6.63 1.09 to 40 <0.001
EP - electrophysiology; LBBB - left bundle branch block; LVEF - left ventricular ejection 
fraction; MI - myocardial infarction
Table 2. Risk factors for outcome of death: Univariate analysis and 
binary logistic regression
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abnormalities, leading to therapy to prevent recurrent syncope, 
but also to determine prognosis. Therapy directed at treating the 
underlying abnormality (most commonly sustained ventricular 
tachycardia and conduction disorders) has been associated 
with a reduction in the risk of death and recurrent syncope. 
Based on our results, it appears that syncope in the face of 
structural heart disease and abnormal EP study results is asso-
ciated with a poor outcome. There are some abnormalities at EP 
study that may reflect the true cause of syncope but have less 
prognostic meaning, e.g. supraventricular tachycardia, pro-
longed AV nodal refractory period. It is worthy to note that the 
use of EP study results, in order to guide therapy, is disease and 
stimulation protocol specific.
 In this study, we also addressed the rate of deaths and what 
are the predictors of mortality in patients with unexplained syn-
cope and suspected cardiac cause. Our investigation revealed 
that in patients with unexplained syncope in whom a cardiac 
cause is suspected, LBBB, severe LV dysfunction, absence of 
prodromal symptoms and male gender are predictive of a car-
diac cause. An interesting new finding in our study was that the 
clinical features including the presence of prodromal symptoms, 
the time interval between the first and last episode of syncope, 
the number of syncope episodes, age, sex, and history of injury 
have a limited role in predicting a cardiac cause of syncope 
(4, 10, 20). Whereas, the finding of Moya et al. (10) shows clinical 
conditions suggestive of a serious cause of syncope include 
occurrence during either whilst supine or exertion. Prodromal 
symptoms of angina pectoris, acute dyspnea and sudden onset 
palpitation with lightheadedness may all suggest a serious car-
diac cause.
Our data indicate that a history of MI, structural heart dis-
ease, LV dysfunction, abnormal ECG at presentation, use of 
diuretics, ventricular arrhythmias, and abnormal EP study result 
are associated with adverse outcome of death. Moreover, simi-
lar to that of Freedman et al. (21), our study suggests that the 
presence of LBBB is an independent risk factor associated with 
mortality. In a subgroup of patients without structural heart dis-
ease, severe outcome could not be predicted by clinical charac-
teristics and/or EP study result.
Although individuals who present with syncope and are 
prone to sudden cardiac death, frequently have a history of 
structural heart disease along with clinical, echocardiographic 
or ECG characteristics suggestive of a serious arrhythmia 
however, it is noteworthy that presence of structural heart 
disease per se does not necessarily imply that the syncopal 
event is caused by the underlying heart disorder (22). Even for 
patients with cardiac disease in whom an arrhythmia is sus-
pected as the cause of syncope, the etiology could be difficult 
to determine.
The prognosis of majority of patients is favorable, but varies 
widely depending on diagnosis; specifically cardiac causes (23-
25). A number of studies have notified the prognosis of syncope, 
highlighted its remarkable variability according to the different 
causes that underlie the loss of consciousness (7, 26-28). In 
particular, cardiac syncope had the worst prognosis compared 
to the absence of mortality at 12 months in neurally mediated 
syncope (14, 26). It is intriguing that the study concludes that the 
good prognosis associated with a negative EP study outweighs 
the implications of the LV dysfunction for a poor prognosis. 
Treatment guided by EP study diagnoses in syncope patient is 
associated with an improved prognosis. A normal or non-diag-
nostic study carries a favorable prognosis.
Study limitations
There is no gold standard of reference for measuring the 
diagnostic tests. As such, there is no ideal pattern or set of cri-
teria for diagnosing syncope. In this study, we employed the 
diagnostic criteria that most commonly used. We focused on a 
composite endpoint of mortality, and the rate of other severe 
adverse outcomes (i.e. major therapeutic procedures) was not 
assumed.
Conclusion
The present study provides evidence that presence of LBBB, 
abnormal EP study result and structural heart disease have 
prognostic value in patients with suspected cardiac cause of 
syncope. The non-diagnostic EP study has an important implica-
tion: a patient with structural heart disease and unexplained 
syncope who has a negative EP study has a good long-term 
prognosis even in the presence of LV dysfunction.
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